Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003170 · ClinicalTrials.gov registry record
Etiology and Early Diagnosis of Neurodevelopmental Disorders
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 576
- Enrollment target
NCT02003170: Completed study, sponsored by University of Arkansas.
NCT02003170 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 576 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02003170 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 576 participants
- Enrollment target
Study Summary
The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Primary Outcome
It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2012-05 |
| Est. Completion | 2024-06-06 |
What the finished NCT02003170 record still lists
NCT02003170 is an observational study that tracks outcomes without assigning an intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02003170 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02003170 about?
NCT02003170 is a clinical study titled "Etiology and Early Diagnosis of Neurodevelopmental Disorders". The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
What is the current status of trial NCT02003170?
This trial is currently completed. The enrollment target is 576 participants. The study started on 2012-05. Estimated completion is 2024-06-06.
Who is sponsoring clinical trial NCT02003170?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
- NCT05179369 · 576 participants · NA
Well-Mama Community Doula Navigator Study
- NCT06398509 · 576 participants · NA
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia